Literature DB >> 22005889

Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator.

Alberto Migliore, Emanuele Bizzi, Serena Broccoli, Bruno Laganà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22005889     DOI： 10.1007/s10067-011-1862-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  4 in total

1.  Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Authors:  Christian E Antoni; Arthur Kavanaugh; Bruce Kirkham; Zuhre Tutuncu; Gerd R Burmester; Udo Schneider; Daniel E Furst; Jerry Molitor; Edward Keystone; Dafna Gladman; Bernhard Manger; Siegfried Wassenberg; Ralf Weier; Daniel J Wallace; Michael H Weisman; Joachim R Kalden; Josef Smolen
Journal:  Arthritis Rheum       Date:  2005-04

2.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

Authors:  P J Mease; B S Goffe; J Metz; A VanderStoep; B Finck; D J Burge
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

3.  Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.

Authors:  C Antoni; G G Krueger; K de Vlam; C Birbara; A Beutler; C Guzzo; B Zhou; L T Dooley; A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-01-27       Impact factor: 19.103

4.  Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

Authors:  Mark C Genovese; Philip J Mease; Glen T D Thomson; Alan J Kivitz; Renee J Perdok; Mark A Weinberg; John Medich; Eric H Sasso
Journal:  J Rheumatol       Date:  2007-04-15       Impact factor: 4.666
  4 in total
  2 in total

1.  Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis.

Authors:  Alberto Migliore; Emanuele Bizzi; Mauro Bernardi; Andrea Picchianti Diamanti; Bruno Laganà; Lea Petrella
Journal:  Clin Drug Investig       Date:  2015-01       Impact factor: 2.859

Review 2.  Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis.

Authors:  Matthew Richard Cawson; Stephen Andrew Mitchell; Chris Knight; Henry Wildey; Dean Spurden; Alex Bird; Michelle Elaine Orme
Journal:  BMC Musculoskelet Disord       Date:  2014-01-20       Impact factor: 2.362
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.